For the first time in over 100 years, American average life expectancies have declined for three consecutive years. Here's a ...

Fifty years of economic change have taken a heavy toll on some Americans, especially those with less education who not only have been left behind but are sicker and living shorter lives, according to ...

The US Food and Drug Administration (FDA) has awarded breakthrough therapy designation to uniQure's AMT-130 for treating Huntington's disease, a rare neurodegenerative condition. This designation ...

Glasgow and Blackpool have the lowest life expectancy in Britain, with locals blaming cheap booze, poor diet, drugs, lack of work opportunities and mental health issues. Figures from the Office ...

A groundbreaking study published in PLOS One indicates that a landmark federal plan could increase average life expectancy for all Americans by 2.6 years while significantly improving overall well ...

Qure's long-term success hinges on overcoming regulatory and logistical challenges. See why I rate QURE stock a hold.

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease ...

A drug originally developed for high blood pressure could find a new use in the treatment of Huntington's disease, thanks to an artificial intelligence-based drug discovery programme at Spain's ...